I’m wary of treading into medical science comparisons, but some differences between ANP (ATL1102) and CAPR (CAP1002) imo on a cursory analysis.
1. CAP1002 is in phase three (pivotal) trial stage (HOPE-3) and has 4 years of data on their P2 trial (one year blinded with placebo, a gap year and then 2 years of OLE).
2. CAP1002 P2 and P3 trials include placebo group
3. CAP1002 - Intravenous doses every 3 months versus ATL1102 injections every week
4. CAP102 Results include cardio function as well as PUL 2.0. 6 of 9 boys had improved cardio function after two year OLE (open label extension) in P2 trial. ATL1102 is yet to prove it can affect heart function. I recall reading somewhere that this was a challenge with antisense oligonucleotides. Someone with more medical knowledge could correct me here.
5. Correct me if I’m wrong but CAP1002 trials cover both ambulant and non-ambulant boys
6. No toxicity issues and a US pathway well established. In ongoing meetings with FDA that they will soon publish minutes of the latest.
7. They create, own and develop their drugs. No licensing and/or payaway or limit to creating new drugs.
8. They have a distribution agreement in place for US and Japan markets with Nippon Shinyaku.
9. CAPR have 77 employees, 8 directors and 10 scientific advisors.
Apart from the above, ATL1102 could be a better treatment.
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-2407
-
-
- There are more pages in this discussion • 1,120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $67.61M |
Open | High | Low | Value | Volume |
7.7¢ | 7.8¢ | 7.4¢ | $24.63K | 325.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 142779 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8181 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 142779 | 0.073 |
2 | 147362 | 0.072 |
2 | 310000 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8181 | 1 |
0.078 | 125476 | 3 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
0.081 | 125000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |